Overview
Take the same result to two clinicians and you can get two different responses. One says it is normal. The other says it is within range but not optimal. Neither is necessarily wrong, because they are using different frameworks — and understanding which is which tells you a great deal about the advice you are being given.
| Reference range | "Optimal" range | |
|---|---|---|
| Where it comes from | The middle ~95% of a measured reference population | A clinician's or vendor's judgment about where people function best |
| What it claims | This is where most people fall | This is where you should be |
| Evidence behind it | Statistical, transparent, lab-specific | Varies enormously — occasionally good, frequently asserted |
| Where it is genuinely strong | Detecting disease. Standardized, defensible | A few markers with outcome data behind tighter targets |
| Where it falls down | A wide range can contain meaningful difference | Used to justify treating people who are well |
| Who uses it | Conventional practice, guidelines | Functional and wellness medicine, most supplement marketing |
Our position, stated plainly: where you sit within a range is genuine information. It is not a diagnosis, and "suboptimal" is not a condition.
How a reference range is actually built
This is the part that makes everything else make sense.
A laboratory recruits a reference population — people considered healthy — measures the analyte, and reports the range containing the middle 95%. By construction, 2.5% of healthy people fall below and 2.5% above.
Which has two immediate consequences.
If you run a panel of twenty analytes on a completely healthy person, the probability that at least one comes back outside range is high — not because anything is wrong, but because that is what a 95% interval does twenty times over. This is the main reason broad panels generate incidental findings.
And because the range describes a population, it shifts with that population. In a population where insulin resistance and vitamin D insufficiency are common, the range reflects that. "Within range" is a statement about your peers, not about your physiology.
Ranges also vary by laboratory, by assay and often by age and sex. A result from one lab is not always comparable with one from another — which matters more than most people realize when tracking a value over time.
Where the "optimal range" idea is legitimate
It is not all marketing, and it would be dishonest to say so.
For some markers there is genuine outcome evidence supporting targets tighter than the reference range. Blood pressure is the clearest example — treatment targets are set by trial evidence, not by where the population sits. Lipids are similar: ApoB and LDL targets are risk-based, and "within reference range" is a low bar when cardiovascular disease is the leading cause of death.
There is also a defensible narrower version of the argument: position within range carries information. A ferritin at the very bottom of range in someone with fatigue and hair shedding is worth taking seriously, because ferritin depletes before the blood count moves. A free T3 at the floor of range in someone with a full symptom picture is worth a conversation.
That is a reasonable clinical instinct. It becomes a problem when it hardens into a fixed target applied to everyone.
Where it gets oversold
Three failure modes, and they are common.
Targets asserted rather than evidenced. A specific "optimal" number gets quoted with confidence and no source. Ask where it comes from and the answer is frequently a textbook, a conference talk or another clinic's website. That is not the same as outcome data.
Treating people who are well. If the range is redefined tightly enough, almost everyone becomes suboptimal — and there is always something to sell them. This is the structural problem with the framework, and it is why we are careful with it despite selling testing ourselves.
Ignoring assay variation. A target quoted to one decimal place, applied to a result from a laboratory whose assay differs from the one the target was derived on, is precision that is not really there.
How we try to hold both
We use reference ranges as the starting point because they are transparent and defensible.
We pay attention to where in the range a result sits, particularly for ferritin, B12, free T3 and vitamin D, where the low end genuinely can be symptomatic.
We reason toward risk-based targets where real outcome evidence exists — blood pressure, ApoB, HbA1c.
And we are explicit when we are exercising judgment rather than citing evidence. Several posts in this library say so directly: we decline to print an "optimal" fasting insulin figure or a HOMA-IR threshold precisely because those are interpretive rather than established, and printing them as fact would be the thing we are describing here.
The most useful comparison of all is usually not against any range. It is against your own previous result, from the same laboratory. A ferritin that has halved over two years is meaningful even if both values sat within range.
Questions worth asking about any target you are given
- Where does this number come from — a trial, a guideline, or someone's practice?
- Does it account for my age, sex and the assay this laboratory uses?
- What happens if I do nothing? Is there evidence that moving this number changes an outcome?
- Am I being treated for a symptom, a risk, or a number?
- What is being sold alongside this recommendation?
That last one is not cynicism. It is the question we would want asked of us.
Frequently asked questions
Is "optimal range" pseudoscience? Not inherently. For some markers there is real evidence behind tighter targets. The problem is that the framework is also used to justify treating well people, and the two versions look identical from the outside.
My result is at the very bottom of range. Does that matter? It might, and it depends on the marker and on your symptoms. It matters more for ferritin, B12 and free T3 than for most others. It is a reason to look closer, not a diagnosis.
Why do reference ranges differ between labs? Different assays, different reference populations, different methods. It is why tracking a value at the same laboratory is more informative than comparing across them.
Should I be worried if one result is out of range? Usually not on its own. With twenty analytes, one falling outside a 95% interval is expected in a healthy person. The pattern matters more than any single flag.
How often should I re-test? Depends on the marker — some move over months, some over years. More often is not better, and it reliably produces findings that generate follow-up without improving anything.
Where this fits in your plan
The useful frame is not normal versus optimal. It is: what does this result mean for me, given my age, my symptoms, my history and what my previous results looked like.
That requires a panel read as a whole, by someone willing to say when they are applying judgment rather than citing evidence.
We measure first. Then we act.
Diagnostic testing does not diagnose or rule out disease on its own and is interpreted by a licensed provider alongside your history and examination.
Ready to start your second act?
It starts with measuring, not guessing. A short, clinician-reviewed assessment shows what fits you.
This article is educational and is not medical advice. Treatments are available only to eligible patients following clinical evaluation and within applicable regulations. Individual results vary.
